Targeting the missing links for cancer therapy

Nature Medicine

Volumn 17, Issue 3, 2011, Pages 283-284

  Polyak, Kornelia ^a,b   Garber, Judy ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BRCA1 PROTEIN; BRCA2 PROTEIN; CARBOPLATIN; CISPLATIN; GEMCITABINE; IMATINIB; INIPARIB; IRINOTECAN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; OLAPARIB; TEMOZOLOMIDE; TRASTUZUMAB; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW SUPPRESSION; BREAST CANCER; BREAST TUMOR; CANCER CELL; CANCER THERAPY; CHILDHOOD LEUKEMIA; CHRONIC MYELOID LEUKEMIA; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HALF LIFE; DRUG POTENCY; DRUG RESPONSE; DRUG SENSITIVITY; DRUG TARGETING; DRUG TOLERABILITY; GENE MUTATION; GLIOBLASTOMA; HOMOLOGOUS RECOMBINATION; HUMAN; MAXIMUM TOLERATED DOSE; NAUSEA AND VOMITING; OVARY CANCER; OVARY TUMOR; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE TUMOR; TESTIS CANCER; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC AGENTS; DRUG DESIGN; HUMANS; MUTATION; NEOPLASM PROTEINS; NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES;

EID: 79952409338     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0311-283     Document Type: Article

References (13)

1. Merlo, L.M., Pepper, J.W., Reid, B.J. & Maley, C.C. Nat. Rev. Cancer 6, 924-935 (2006).
2. Murdoch, D. & Sager, J. Curr. Opin. Oncol. 20, 104-111 (2008).
3. Kaelin, W.G. Jr. Nat. Rev. Cancer 5, 689-698 (2005).
4. Farmer, H. et al. Nature 434, 917-921 (2005).
5. Bryant, H.E. et al. Nature 434, 913-917 (2005).
6. Schultz, N., Lopez, E., Saleh-Gohari, N. & Helleday, T. Nucleic Acids Res. 31, 4959-4964 (2003).
7. Fong, P.C. et al. N. Engl. J. Med. 361, 123-134 (2009).
8. Carey, L.A. & Sharpless, N.E. N. Engl. J. Med. 364, 277-279 (2011).
9. O'Shaughnessy, J. et al. N. Engl. J. Med. 364, 205-214 (2011).
10. Dedes, K.J. et al. Sci. Transl. Med. 2, 53ra75 (2010).
11. Ashworth, A. Cancer Res. 68, 10021-10023 (2008).
12. Edwards, S.L. et al. Nature 451, 1111-1115 (2008).
13. Ferraris, D.V. J. Med. Chem. 53, 4561-4584 (2010).